Posted by Michael Wonder on 18 Aug 2020
The FDA response to COVID-19 at six months: regulatory innovation in the face of a pandemic
18 August 2020 - The COVID-19 pandemic has significantly impacted American society, with more than 160,000 deaths and 5 million cases as of August 2020.
A novel pathogen like SARS-CoV-2 is uniquely challenging because of the real-time learning curve imposed on the medical and scientific communities to understand how the virus works and how best to detect infections, treat their effects, and contain further spread.
To meet these challenges, the all-hazards preparedness framework of the FDA equips the agency with specific authorities for use during emergency situations.
